Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

Bloomberg News reports that U.S. and European health regulators have found Johnson & Johnson’s anti-fungal Nizoral tablets to “raise the risk of deadly liver injuries and harmful drug interactions” and are recommending that “their use should...
Reuters reports that Rockwell Medical‘s “late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease [CKD].” The study tested Soluble Ferric...
Reuters reports that Celgene Corp has met their goal in treatment of blood cancer patients with a drug called Revlimid. Revlimid has already been approved for “use in multiple myeloma patients who have failed at least one prior therapy, mantle cell...